Aromatase Inhibitor-Associated Arthralgias

被引：20
|
作者：
Chlebowski, Rowan T. [1 ]
机构：
[1] Harbor UCLA Med Ctr, Dept Med, Los Angeles BioMed Res Inst, Torrance, CA 90509 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 30期
关键词：
PLUS VITAMIN-D; BREAST-CANCER; MUSCULOSKELETAL SYMPTOMS; POSTMENOPAUSAL WOMEN; JOINT SYMPTOMS; TENOSYNOVIAL CHANGES; ADJUVANT TREATMENT; BONE HEALTH; PAIN; TRIAL;
D O I：
10.1200/JCO.2009.23.3270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4032 / 4034
页数：4
相关论文
共 50 条
  • [41] Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer
    Aapro, M. S.
    Hadji, P.
    Brufsky, A.
    Tubana-Hulin, M.
    Guise, T.
    Body, J. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 186 - 186
  • [42] Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss
    Chu, Meiling
    Zhou, Yue
    Yin, Yulian
    Jin, Lan
    Chen, Hongfeng
    Meng, Tian
    He, Binjun
    Wu, Jingjing
    Ye, Meina
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Aromatase inhibitor-associated musculoskeletal pain: taking 'AIM' at a symptom in breast cancer survivors
    Henry, N. Lynn
    PAIN MANAGEMENT, 2011, 1 (03) : 191 - 193
  • [44] Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics
    Liu, Mohan
    Goss, Paul E.
    Ingle, James N.
    Kubo, Michiaki
    Furukawa, Yoichi
    Batzler, Anthony
    Jenkins, Gregory D.
    Carlson, Erin E.
    Nakamura, Yusuke
    Schaid, Daniel J.
    Chapman, Judy-Anne W.
    Shepherd, Lois E.
    Ellis, Matthew J.
    Khosla, Sundeep
    Wang, Liewei
    Weinshilboum, Richard M.
    MOLECULAR ENDOCRINOLOGY, 2014, 28 (10) : 1740 - 1751
  • [45] Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study
    Henry, N. L.
    Pchejetski, D.
    A'Hern, R.
    Nguyen, A. T.
    Charles, P.
    Waxman, J.
    Li, L.
    Storniolo, A. M.
    Hayes, D. F.
    Flockhart, D. A.
    Stearns, V.
    Stebbing, J.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 291 - 296
  • [46] Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study
    DeNysschen, C. A.
    Burton, H.
    Ademuyiwa, F.
    Levine, E.
    Tetewsky, S.
    O'Connor, T.
    EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 (04) : 493 - 501
  • [47] Assessment of the impact of new UK guidelines on the management of aromatase inhibitor-associated bone loss
    Sowden, E.
    Evans, B.
    Greenbank, C. M.
    Bukhari, M.
    Halsey, J. P.
    RHEUMATOLOGY, 2009, 48 (02) : 197 - 198
  • [48] Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
    Bauer, M.
    Bryce, J.
    Hadji, P.
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 91 - 101
  • [49] Assessment of an algorithm for prevention of aromatase inhibitor-associated bone loss: two year results
    White, K. L.
    Yeow, E.
    Beith, J.
    Lee, C. P.
    Broad, A.
    Sewak, S.
    Abdi, E.
    Sambrook, P. N.
    Bell, R.
    EJC SUPPLEMENTS, 2010, 8 (03): : 161 - 161
  • [50] Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors
    Romero, Sally A. D.
    Su, H. Irene
    Satagopan, Jaya
    Li, Q. Susan
    Seluzicki, Christina M.
    Dries, Annika
    DeMichele, Angela M.
    Mao, Jun J.
    BREAST, 2020, 49 : 48 - 54
12345